Clinical Trial Details
| Trial ID: | L4740 |
| Source ID: | NCT05072990 |
| Associated Drug: | Chinese Herb Medicine |
| Title: | Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus in Obese|Dyslipidemia Associated With Type II Diabetes Mellitus |
| Interventions: | DRUG: Chinese herb medicine |
| Outcome Measures: | Primary: Change from Baseline HbA1c at 3 months, 6 months, 0 month, 3 months, 6 months|Changes from Baseline Fasting Blood Glucose at 3 months, 6 months, 0 month, 3 months, 6 months|Changes from Baseline Low Density Lipoprotein at 3 months, 6 months, 0 month, 3 months, 6 months|Changes from Baseline Triglyceride at 3 months, 6 months, 0 month, 3 months, 6 months|Changes from Baseline Body Mass Index at 3 months, 6 months, 0 month, 3 months, 6 months | Secondary: Changes from Postprandial Blood Glucose at 6 months, 0 month, 6 months|Changes from Total Cholesterol at 6 months, 0 month, 6 months|Changes from High Density Lipoprotein at 6 months, 0 month, 6 months|Changes from Systolic Blood Pressure at 6 months, 0 month, 6 months|Changes from Diastolic Blood Pressure at 6 months, 0 month, 6 months |
| Sponsor/Collaborators: | Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 95 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2021-10-27 |
| Completion Date: | 2022-05-15 |
| Results First Posted: | |
| Last Update Posted: | 2023-09-15 |
| Locations: | Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, 100053, China |
| URL: | https://clinicaltrials.gov/show/NCT05072990 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|